Room 20A (San Diego Convention Center)
**This session is eligible for CME credit**
Supported by Astra Zeneca LP
Julie Ann Sosa, MD, FACS, Duke University, Durham, NC
Thyroid cancer incidence is increasing in the United States, as well as other countries around the world. There is signficant controversy if this increased incidence represents an actual increase or is due to the changing approaches to diagnosis. A number of studies have suggested that obesity is associated with an increased risk of thyroid cancer and may be playing a role in the increased incidence of thyroid cancer.
Disclosure: SIS: Consultant, Amgen, Member of advisory committees or review panels, Bayer, Inc., Member of advisory committees or review panels, Eisai, Consultant, Eli Lilly & Company, Consultant, Exelixis, Inc., Clinical Researcher, Genzyme Corporation, Member of advisory committees or review panels, Novo Nordisk, Scientific Board Member, Veracyte, Inc..